Literature DB >> 8627307

Characterization of dp6troglycan-laminin interaction in peripheral nerve.

H Yamada1, A Chiba, T Endo, A Kobata, L V Anderson, H Hori, H Fukuta-Ohi, I Kanazawa, K P Campbell, T Shimizu, K Matsumura.   

Abstract

Dystoroglycan is encoded by a single gene and cleaved into two proteins, alpha and beta-dystroglycan, by posttranslational processing. The 120kDa peripheral nerve isoform of alpha-dystroglycan binds laminin-2 comprised of the alpha 2, beta 1, and gamma 1 chains. In congenital muscular dystrophy and dy mice deficient in laminin alpha 2 chain, peripheral myelination is disturbed, suggesting a role for the dystroglycan- laminin interaction in peripheral myelinogenesis. To begin to test this hypothesis, we have characterized the dystroglycan-laminin interaction in peripheral nerve. We demonstrate that (1) alpha-dystroglycan is an extracellular peripheral membrane glycoprotein that links beta-dystroglycan in the Schwann cell outer membrane with laminin-2 in the endoneurial basal lamina, and (2) dystrophin homologues Dp116 and utrophin are cytoskeletal proteins of the Schwann cell cytoplasm. We also present data that suggest a role for glycosylation of alpha-dystroglycan in the interaction with laminin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627307     DOI: 10.1046/j.1471-4159.1996.66041518.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

1.  Effect of beta-dystroglycan processing on utrophin/Dp116 anchorage in normal and mdx mouse Schwann cell membrane.

Authors:  K Hnia; G Hugon; A Masmoudi; J Mercier; F Rivier; D Mornet
Journal:  Neuroscience       Date:  2006-06-02       Impact factor: 3.590

2.  Cloning and expression of a novel UDP-GlcNAc:alpha-D-mannoside beta1,2-N-acetylglucosaminyltransferase homologous to UDP-GlcNAc:alpha-3-D-mannoside beta1,2-N-acetylglucosaminyltransferase I.

Authors:  Wenli Zhang; Doron Betel; Harry Schachter
Journal:  Biochem J       Date:  2002-01-01       Impact factor: 3.857

3.  Enhanced laminin binding by alpha-dystroglycan after enzymatic deglycosylation.

Authors:  Ariana C Combs; James M Ervasti
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

4.  A 21-kDa surface protein of Mycobacterium leprae binds peripheral nerve laminin-2 and mediates Schwann cell invasion.

Authors:  Y Shimoji; V Ng; K Matsumura; V A Fischetti; A Rambukkana
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

5.  Laminin and alpha-dystroglycan mediate acetylcholine receptor aggregation via a MuSK-independent pathway.

Authors:  F Montanaro; S H Gee; C Jacobson; M H Lindenbaum; S C Froehner; S Carbonetto
Journal:  J Neurosci       Date:  1998-02-15       Impact factor: 6.167

Review 6.  A journey to the world of glycobiology.

Authors:  A Kobata
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

7.  Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE.

Authors:  Kei-ichiro Inamori; Takako Yoshida-Moriguchi; Yuji Hara; Mary E Anderson; Liping Yu; Kevin P Campbell
Journal:  Science       Date:  2012-01-06       Impact factor: 47.728

Review 8.  Biological role of dystroglycan in Schwann cell function and its implications in peripheral nervous system diseases.

Authors:  Toshihiro Masaki; Kiichiro Matsumura
Journal:  J Biomed Biotechnol       Date:  2010-06-15

9.  Chronic hypoxia impairs muscle function in the Drosophila model of Duchenne's muscular dystrophy (DMD).

Authors:  Matias Mosqueira; Gabriel Willmann; Hannele Ruohola-Baker; Tejvir S Khurana
Journal:  PLoS One       Date:  2010-10-20       Impact factor: 3.240

10.  Identification of alpha-dystroglycan binding sequences in the laminin alpha2 chain LG4-5 module.

Authors:  Nobuharu Suzuki; Kentaro Hozumi; Shunsuke Urushibata; Takashi Yoshimura; Yamato Kikkawa; Jessica D Gumerson; Daniel E Michele; Matthew P Hoffman; Yoshihiko Yamada; Motoyoshi Nomizu
Journal:  Matrix Biol       Date:  2009-09-29       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.